12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed significant movement. Qilian Intl Hldg Gr (QLI) led the gainers with a 73.2% increase, while Vivos Therapeutics (VVOS) experienced the largest drop among the losers, falling 12.6%. Notably, Dare Bioscience (DARE), Vivos Therapeutics (VVOS), and Pulse Biosciences (PLSE) released their Q4 earnings reports, influencing their stock movements.

March 28, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dare Bioscience stock rose 12.19% to $0.55 after their Q4 earnings report, with a market cap of $54.2 million.
The increase in DARE's stock price following their earnings report suggests a favorable investor response to their financial results.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Qilian Intl Hldg Gr shares surged 73.2% in after-market trading, with a market cap of $39.3 million.
The substantial increase in QLI's stock price indicates strong investor interest, potentially due to positive market sentiment or speculative trading.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Pulse Biosciences stock decreased by 11.37% to $7.72 after their Q4 earnings, with a market cap of $425.2 million.
The drop in PLSE stock price post-earnings indicates a negative market reaction to their Q4 financial performance.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Vivos Therapeutics stock fell 12.6% after the release of their Q4 earnings report, with a market value of $5.6 million.
The decline in VVOS stock price post-earnings suggests the market reacted negatively to their Q4 financial performance.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90